Sort
11,323 grants matching “glioblastoma”
Quantitative MRSI for the prediction of response to chemoradiation therapy in GBM
$18,482James Scott Cordova · Emory University · F31 · FY2016 · CA
CD44 Antagonists in Targeted and Combinational Therapy for Glioblastoma
$18,455Qin Yu · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · CA
The Unfolded Protein Response in Glioblastoma
$18,379Briana Prager · Cleveland Clinic Lerner Com-Cwru · F30 · FY2017 · CA
Analytical Immunopharmacology
$18,367Timothy W Synold · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA
Targeting ATF5 for intervention in brain cancer
$18,364Angelo D Arias · University Of California At Davis · F31 · FY2009 · CA
A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy
$18,245Katherine A. Riccione · Duke University · F31 · FY2017 · CA
Early assessment of radiation response in brain tumors using quantitative temporal diffusion spectroscopy
$18,221Xiaoyu Jiang · Vanderbilt University Medical Center · F32 · FY2018 · CA
A PHASE 2 STUDY OF AZD2171 IN RECURRENT GLIOBLASTOMA (NCI PROTOCOL #7105)
$18,003Tracy T Batchelor · Massachusetts General Hospital · M01 · FY2007 · RR
Pathology Core
$17,999Jason Huse · Fred Hutchinson Cancer Research Center · U54 · FY2013 · CA
Mechanistic Insights and Diagnostic Applications for Hypoxia-Induced Vasorin in Pancreatic Cancer
$17,953Lisa Kirkemo · University Of California, San Francisco · F31 · FY2022 · CA
METABOLISM IN HUMAN GLIOMAS
$17,838Elizabeth A Maher · Ut Southwestern Medical Center · P41 · FY2009 · RR
Pathology Core
$17,738Jason Huse · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
Pathology Core
$17,703Jason Huse · Fred Hutchinson Cancer Research Center · U54 · FY2014 · CA
Epigenetic Regulation of Lipid Metabolism in Glioma Stem Cells
$17,608Ryan Christopher Gimple · Cleveland Clinic Lerner Com-Cwru · F30 · FY2017 · CA
Intratumoral/interstitial therapy of glioblastoma
$17,441Medical University Of South Carolina · M01 · FY2000 · RR
Elucidating Reversible Drug Resistance in Glioblastoma
$16,960Fadi John Najm · Harvard Medical School · F31 · FY2019 · CA
Program 2: Cancer Imaging Program (CIP)
$16,667Jennifer K. Barton · University Of Arizona · P30 · FY2018 · CA
SCH52365: PHASE I STUDY OF CYCLIC ORAL ADMINISTRATION
$16,409University Of Texas Hlth Sci Ctr San Ant · M01 · FY2000 · RR
IN VIVO MR PERMEABILITY IN MOUSE XENOGRAFT MODEL OF GLIOBLASTOMA MULTIFORMA
$16,380Gerald Arthur Grant · Duke University · P41 · FY2010 · RR
IN VIVO MR PERMEABILITY IN MOUSE XENOGRAFT MODEL OF GLIOBLASTOMA MULTIFORMA
$16,380Gerald Arthur Grant · Duke University · P41 · FY2009 · RR
2024 BTEC conference (5/14/24 to 5/17/24)
$16,317Quinn T Ostrom · Duke University · R13 · FY2024 · CA
Gene and Virus Therapy Program
$16,215Evanthia Galanis · Mayo Clinic Rochester · P30 · FY2019 · CA
2023 Basic Mechanisms to Clinical Trials in Brain Tumors Gordon Research Conference
$16,000Sadhan Majumder · Gordon Research Conferences · R13 · FY2023 · CA
Pathology Core
$15,930Jason Huse · Fred Hutchinson Cancer Research Center · U54 · FY2015 · CA
PROGRAM LEADERS--CANCER BIOLOGY
$15,701Larry Donehower · Baylor College Of Medicine · P30 · FY2010 · CA